Application of β-blockers for hypertension
10.12092/j.issn.1009-2501.2022.04.011
- Author:
Sumei CUI
1
;
Zhaoqiang CUI
2
Author Information
1. Department of Emergency Medicine, Qilu Hospital of Shandong University
2. Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University
- Publication Type:Journal Article
- Keywords:
Antihypertensives;
Hypertension;
β-blocker
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2022;27(4):423-427
- CountryChina
- Language:Chinese
-
Abstract:
β-blockers are widely administered to patients with various cardiovascular diseases including hypertension. However, in recent years, studies have questioned or even denied the antihypertensive effect of β-blockers, which has caused confusion to cardiovascular clinicians. Based on the systematic analysis of a number of studies, the author believes that β-blockers still remain the status as the first-line antihypertensives.
